GE has provided the FDA with the device description and non-clinical information, including phantom testing, and detector performance evaluation
WAUKESHA, WI -- NOVEMBER 10, 2011-- GE Healthcare, a unit of General Electric Company (NYSE:GE), announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the first module of its premarket approval application (PMA) for GE Breast Tomosynthesis, an option of the Senographe* Essential system.
* THREE-YEAR GRANT TO ESTABLISH A CARE MANAGEMENT MEDICAL HOME CENTER FOR 10,000 MIAMI DADE PATIENTS SUFFERING FROM CHRONIC DIABETES
* LARGEST GRANT TO DATE FROM DEVELOPING HEALTH™ PROGRAM TO IMPROVE HEALTHCARE IN UNDERSERVED COMMUNITIES AND THE FIRST SUCH GRANT IN FLORIDA
* GE PROGRAM HAS PROVIDED $17M IN GRANTS IN THE U.S. SINCE 2009
Dubai, UAE; November 10, 2011: GE Aviation has appointed Isam Moursy as General Manager for its Middle East and Africa (MEA) markets. A veteran of GE with over 20 years of experience, Moursy will focus on strengthening the aviation business of the company by building long-term strategic partnerships, training, service and localization.
